<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7744152\results\search\disease\results.xml">
  <result pre="promising candidate for further preclinical investigations. Keywords Steroid sulphatase hormone-dependent" exact="cancer" post="breast cancer STS inhibitors triazoles fig-count: table-count: page-count: word-count:"/>
  <result pre="candidate for further preclinical investigations. Keywords Steroid sulphatase hormone-dependent cancer" exact="breast cancer" post="STS inhibitors triazoles fig-count: table-count: page-count: word-count: Introduction Cancer"/>
  <result pre="for further preclinical investigations. Keywords Steroid sulphatase hormone-dependent cancer breast" exact="cancer" post="STS inhibitors triazoles fig-count: table-count: page-count: word-count: Introduction Cancer"/>
  <result pre="tumour-related deaths in 2018 worldwide1. The most common types of" exact="cancer" post="are lung, breast, colorectal, prostate, and stomach, which constitute"/>
  <result pre="Institute estimates that more than 270â€‰000 (15.3%) new cases of" exact="breast cancer" post="will be diagnosed and more than 42â€‰000 (7.0%) deaths"/>
  <result pre="estimates that more than 270â€‰000 (15.3%) new cases of breast" exact="cancer" post="will be diagnosed and more than 42â€‰000 (7.0%) deaths"/>
  <result pre="the United States of America in 20202. Approximately 95% of" exact="breast cancer" post="cases in the primary stage are hormone-sensitive, and therefore,"/>
  <result pre="United States of America in 20202. Approximately 95% of breast" exact="cancer" post="cases in the primary stage are hormone-sensitive, and therefore,"/>
  <result pre="proliferation of tumours cells3. The biosynthesis of active steroids in" exact="cancer" post="tissues mainly depends on the following three enzymatic pathways:"/>
  <result pre="therefore plays a pivotal role in human steroidogenesis process4â€&quot;7. Current" exact="breast cancer" post="therapies are based on chemotherapeutics that act as selective"/>
  <result pre="plays a pivotal role in human steroidogenesis process4â€&quot;7. Current breast" exact="cancer" post="therapies are based on chemotherapeutics that act as selective"/>
  <result pre="as an attractive molecular target for the development of hormone-dependent" exact="cancer" post="therapies, and therefore, the synthesis of new, efficient, selective"/>
  <result pre="clinical studies) and exhibits quite good results towards treating hormone-dependent" exact="breast cancer" post="(without having inÂ vivo and inÂ vitro oestrogenic properties)14â€&quot;20."/>
  <result pre="studies) and exhibits quite good results towards treating hormone-dependent breast" exact="cancer" post="(without having inÂ vivo and inÂ vitro oestrogenic properties)14â€&quot;20."/>
  <result pre="were performed in triplicate. In vitro cellular assay using MCF-7" exact="breast cancer" post="cell line Inhibition of STS activity in the MCF-7"/>
  <result pre="performed in triplicate. In vitro cellular assay using MCF-7 breast" exact="cancer" post="cell line Inhibition of STS activity in the MCF-7"/>
  <result pre="cancer cell line Inhibition of STS activity in the MCF-7" exact="breast cancer" post="cell line was measured according to the method described"/>
  <result pre="cell line Inhibition of STS activity in the MCF-7 breast" exact="cancer" post="cell line was measured according to the method described"/>
  <result pre="3A-L are able to inhibit STS activity in the MCF-7" exact="cancer" post="cell line. In the course of our study, we"/>
  <result pre="Cell Endocrinol2011;340:154â€&quot;60.21693170 5ShahR, SinghJ, SinghD, et al.Sulfatase inhibitors for recidivist" exact="breast cancer" post="treatment: a chemical review. Eur J Med Chem2016;114:170â€&quot;90.26974384 6ReedMJ,"/>
  <result pre="Endocrinol2011;340:154â€&quot;60.21693170 5ShahR, SinghJ, SinghD, et al.Sulfatase inhibitors for recidivist breast" exact="cancer" post="treatment: a chemical review. Eur J Med Chem2016;114:170â€&quot;90.26974384 6ReedMJ,"/>
  <result pre="aromatase and sulfatase inhibitor. Clin Cancer Res2008;14:6469â€&quot;77.18927286 10DixonJM.Endocrine resistance in" exact="breast cancer." post="New J Sci2014;2014:1â€&quot;7. 11FosterA, ReedPA, PurohitMJ.Recent developments of steroid"/>
  <result pre="17Î²-hydroxysteroid dehydrogenase type 1(17Î²-HSD1) following neoadjuvant aromatase inhibitor therapy in" exact="breast cancer" post="patients. Breast Cancer Res Treat2010;120:639â€&quot;48.20151319 13DaÅ›koM, DemkowiczS, BiernackiK, et"/>
  <result pre="dehydrogenase type 1(17Î²-HSD1) following neoadjuvant aromatase inhibitor therapy in breast" exact="cancer" post="patients. Breast Cancer Res Treat2010;120:639â€&quot;48.20151319 13DaÅ›koM, DemkowiczS, BiernackiK, et"/>
  <result pre="et al.Phase I study of STX 64 (667 Coumate) in" exact="breast cancer" post="patients: the first study of a steroid sulfatase inhibitor."/>
  <result pre="al.Phase I study of STX 64 (667 Coumate) in breast" exact="cancer" post="patients: the first study of a steroid sulfatase inhibitor."/>
  <result pre="17PalmieriC, JanuszewskiA, StanwayS, CoombesRC.Irosustat: a first-generation steroid sulfatase inhibitor in" exact="breast cancer." post="Expert Rev Anticancer Ther2011;11:179â€&quot;83.21342037 18PalmieriC, SteinRC, LiuX, et al.IRIS"/>
  <result pre="inhibitor Irosustat when added to an aromatase inhibitor in ER-positive" exact="breast cancer" post="patients. Breast Cancer Res Treat2017;165:343â€&quot;53.28612226 19PalmieriC, SteinRC, LiuX, et"/>
  <result pre="Irosustat when added to an aromatase inhibitor in ER-positive breast" exact="cancer" post="patients. Breast Cancer Res Treat2017;165:343â€&quot;53.28612226 19PalmieriC, SteinRC, LiuX, et"/>
  <result pre="an aromatase inhibitor in ER positive locally advanced or metastatic" exact="breast cancer" post="patients (IRIS) â€&quot; trial results. J Clin Oncol2016;34:549. 20PalmieriC,"/>
  <result pre="aromatase inhibitor in ER positive locally advanced or metastatic breast" exact="cancer" post="patients (IRIS) â€&quot; trial results. J Clin Oncol2016;34:549. 20PalmieriC,"/>
  <result pre="the activity of the steroid sulfatase inhibitor irosustat in early" exact="breast cancer." post="Breast Cancer Res Treat2017;166:527â€&quot;39.28795252 21PotterBVL.Sulfation pathways: steroid sulphatase inhibition"/>
  <result pre="24KommidiH, GuoH, NuriliF, et al.18F-positron emitting/trimethine cyanine-fluorescent contrast for image-guided" exact="prostate cancer" post="management. J Med Chem2018;61:4256â€&quot;62.29676909 25HuangS, HanY, ChenM, et al.Radiosynthesis"/>
  <result pre="GuoH, NuriliF, et al.18F-positron emitting/trimethine cyanine-fluorescent contrast for image-guided prostate" exact="cancer" post="management. J Med Chem2018;61:4256â€&quot;62.29676909 25HuangS, HanY, ChenM, et al.Radiosynthesis"/>
 </snippets>
</snippetsTree>
